Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer

被引:13
|
作者
Pulido, Daniel [1 ,2 ]
Casado-Anguera, Veronica [3 ]
Gomez-Autet, Marc [4 ]
Llopart, Natalia [3 ]
Moreno, Estefania [3 ]
Casajuana-Martin, Nil [4 ]
Ferre, Sergi [5 ]
Pardo, Leonardo [4 ]
Casado, Vicent [3 ]
Royo, Miriam [1 ,2 ]
机构
[1] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08034, Spain
[2] Inst Adv Chem Catalonia IQAC, Dept Surfactants & Nanobiotechnol, CSIC, Barcelona 08034, Spain
[3] Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[4] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain
[5] NIDA, Integrat Neurobiol Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA
关键词
PROTEIN-COUPLED RECEPTORS; BIVALENT LIGANDS; RECOGNITION PATHWAY; BITOPIC LIGANDS; A(2A) RECEPTOR; GPCR DIMERS; BINDING; DESIGN; FLUORESCENCE; DIMERIZATION;
D O I
10.1021/acs.jmedchem.1c01763
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A G protein-coupled receptor heteromer that fulfills the established criteria for its existence in vivo is the complex between adenosine A(2A) (A(2A)R) and dopamine D-2 (D2R) receptors. Here, we have designed and synthesized heterobivalent ligands for the A(2A)R-D-2R heteromer with various spacer lengths. The indispensable simultaneous binding of these ligands to the two different orthosteric sites of the heteromer has been evaluated by radioligand competition-binding assays in the absence and presence of specific peptides that disrupt the formation of the heteromer, label-free dynamic mass redistribution assays in living cells, and molecular dynamic simulations. This combination of techniques has permitted us to identify compound 26 [K-DB1 (A(2A)R) = 2.1 nM, K-DB1 (D2R) = 0.13 nM], with a spacer length of 43-atoms, as a true bivalent ligand that simultaneously binds to the two different orthosteric sites. Moreover, bioluminescence resonance energy transfer experiments indicate that 26 favors the stabilization of the A(2A)R-D2R heteromer.
引用
收藏
页码:616 / 632
页数:17
相关论文
共 50 条
  • [31] Allosteric mechanisms within the adenosine A2A -dopamine D2 receptor heterotetramer
    Ferre, Sergi
    Bonaventura, Jordi
    Tomasi, Dardo
    Navarro, Gemma
    Moreno, Estefania
    Cortes, Antonio
    Lluis, Carme
    Casado, Vicent
    Volkow, Nora D.
    [J]. NEUROPHARMACOLOGY, 2016, 104 : 154 - 160
  • [32] Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance
    Alves, Ana Cristina de Bem
    Santos, Naiara de Souza
    Santos, Ana Paula Tavares
    da Panatta, Gabriela
    Speck, Ana Elisa
    Cunha, Rodrigo A.
    Aguiar Jr, Aderbal S.
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Disruption of the dopamine D1/D2 heteromer using synthetic peptides
    Champion, Margaret
    Baraka, Adam
    Evans, Hedeel
    Heyl-Clegg, Deborah
    [J]. FASEB JOURNAL, 2017, 31
  • [34] Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay
    Fernandez-Duenas, Victor
    Gomez-Soler, Maricel
    Valle-Leon, Marta
    Watanabe, Masahiko
    Ferrer, Isidre
    Ciruela, Francisco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [35] Dopamine D2 receptor gene polymorphisms and clinical response to dopamine D2 receptor antagonists
    Mihara, K
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S59 - S59
  • [36] The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction
    Filip, M.
    Zaniewska, M.
    Frankowska, M.
    Wydra, K.
    Fuxe, K.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2012, 19 (03) : 317 - 355
  • [37] Trafficking of adenosine A2A and dopamine D2 receptors
    Torvinen, M
    Torri, C
    Tombesi, A
    Marcellino, D
    Watson, S
    Lluis, C
    Franco, R
    Fuxe, K
    Agnati, LF
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 25 (02) : 191 - 200
  • [38] Trafficking of adenosine A2A and dopamine D2 receptors
    Maria Torvinen
    Carla Torri
    Andrea Tombesi
    Daniel Marcellino
    Stan Watson
    Carmen Lluis
    Rafael Franco
    Kjell Fuxe
    Luigi F. Agnati
    [J]. Journal of Molecular Neuroscience, 2005, 25 : 191 - 200
  • [39] Dopamine D2 receptor and obesity
    Chen, JS
    [J]. LANCET, 2001, 357 (9271): : 1883 - +
  • [40] 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity
    Angelina, Emilio
    Andujar, Sebastian
    Moreno, Laura
    Garibotto, Francisco
    Parraga, Javier
    Peruchena, Nelida
    Cabedo, Nuria
    Villecco, Margarita
    Cortes, Diego
    Enriz, Ricardo D.
    [J]. MOLECULAR INFORMATICS, 2015, 34 (01) : 28 - 43